Liver Transplant
Liver Transplant is a medical procedure with 17 clinical trials. Currently 5 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
5
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
Liver Transplantation for Unresectable Liver Limited Colorectal Metastases
Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation
Clinical Trials (17)
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
Liver Transplantation for Unresectable Liver Limited Colorectal Metastases
Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma
Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
The TOGETHER Project - Liver
Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors
To Establish a Blood Transfusion Prediction Model for Liver Transplantation Patients Based on PBM
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
All 17 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 17